| Giulio G Diamante, MD | |
|
1277 Hartford Ave, Johnston, RI 02919-7121 | |
| (401) 521-3606 | |
| (401) 453-3288 |
| Full Name | Giulio G Diamante |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 31 Years |
| Location | 1277 Hartford Ave, Johnston, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851379812 | NPI | - | NPPES |
| 206286 | Other | RI | BLUE CROSS |
| 402867 | Other | RI | BCBS-BLUECHIP |
| 0179060 | Medicaid | MA | |
| 05049869901 | Other | RI | TRICARE NORTH REGION |
| 131000 | Other | RI | COLE VISION SERVICES |
| 2925 | Other | RI | NEIGHBORHOOD HEALTH PLAN OF RI |
| 5720675 | Other | RI | AETNA U.S. HEALTHCARE |
| 1166182 | Other | RI | CIGNA HEALTHCARE |
| 15164FRIH | Other | RI | HARVARD PILG |
| 156217 | Other | RI | TUFTS HEALTH PLAN |
| 180035658 | Other | RI | RAILROAD MEDICARE |
| 9020628 | Medicaid | RI | |
| 050498699 | Other | CA | BCBS-CALIFORNIA |
| 0800472 | Other | RI | UNITED HEALTH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD09553 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Giulio G Diamante Md Inc | 7719098730 | 4 |
| Giulio G Diamante Md Inc | 7719098730 | 4 |
News Archive
Foundation Radiology Group (FRG), a premier provider of diagnostic imaging professional services, headquartered in downtown Pittsburgh, is pleased to announce its new division, FRG Molecular Imaging, which will be led by nationally renowned physician and PET/CT imaging pioneer, Todd M. Blodgett, M.D..
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
At the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics announced today the new Philips Ingenuity CT (computed tomography) platform, an innovative technology that will help redefine low dose imaging.
Researchers from Flinders University and the Robinson Research Institute at the University of Adelaide have identified distinctive biological markers that could improve the routine blood tests pregnant women already undergo and detect risks for pregnancy complications earlier than currently possible.
› Verified 5 days ago
| Entity Name | Giulio G Diamante Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770761660 PECOS PAC ID: 7719098730 Enrollment ID: O20120613000024 |
News Archive
Foundation Radiology Group (FRG), a premier provider of diagnostic imaging professional services, headquartered in downtown Pittsburgh, is pleased to announce its new division, FRG Molecular Imaging, which will be led by nationally renowned physician and PET/CT imaging pioneer, Todd M. Blodgett, M.D..
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
At the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics announced today the new Philips Ingenuity CT (computed tomography) platform, an innovative technology that will help redefine low dose imaging.
Researchers from Flinders University and the Robinson Research Institute at the University of Adelaide have identified distinctive biological markers that could improve the routine blood tests pregnant women already undergo and detect risks for pregnancy complications earlier than currently possible.
› Verified 5 days ago
| Entity Name | Lifespan Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407116643 PECOS PAC ID: 2567455082 Enrollment ID: O20121029000368 |
News Archive
Foundation Radiology Group (FRG), a premier provider of diagnostic imaging professional services, headquartered in downtown Pittsburgh, is pleased to announce its new division, FRG Molecular Imaging, which will be led by nationally renowned physician and PET/CT imaging pioneer, Todd M. Blodgett, M.D..
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
At the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics announced today the new Philips Ingenuity CT (computed tomography) platform, an innovative technology that will help redefine low dose imaging.
Researchers from Flinders University and the Robinson Research Institute at the University of Adelaide have identified distinctive biological markers that could improve the routine blood tests pregnant women already undergo and detect risks for pregnancy complications earlier than currently possible.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Giulio G Diamante, MD 1277 Hartford Ave, Johnston, RI 02919-7121 Ph: (401) 521-3606 | Giulio G Diamante, MD 1277 Hartford Ave, Johnston, RI 02919-7121 Ph: (401) 521-3606 |
News Archive
Foundation Radiology Group (FRG), a premier provider of diagnostic imaging professional services, headquartered in downtown Pittsburgh, is pleased to announce its new division, FRG Molecular Imaging, which will be led by nationally renowned physician and PET/CT imaging pioneer, Todd M. Blodgett, M.D..
Stemedica Cell Technologies, Inc. received the FDA's investigational new drug (IND) approval for a United States-based, Phase IIa clinical study using its allogeneic stem-cell therapy to treat subjects with mild to moderate dementia due to Alzheimer's disease (AD), the sixth leading cause of death in the United States.
At the 96th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics announced today the new Philips Ingenuity CT (computed tomography) platform, an innovative technology that will help redefine low dose imaging.
Researchers from Flinders University and the Robinson Research Institute at the University of Adelaide have identified distinctive biological markers that could improve the routine blood tests pregnant women already undergo and detect risks for pregnancy complications earlier than currently possible.
› Verified 5 days ago
Dr. William J Andreoni, OPHTHALMOLOGIST Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1524 Atwood Ave, Johnston, RI 02919 Phone: 401-272-2110 Fax: 401-273-6236 |